Clinical Trial Details

Trial ID: L0946
Source ID: IRCT201111022709N20
Associated Drug: Olive oil
Title: Effects of Extra Virgin Olive Oil on Serum Hepatic enzymes ?Insulin resistance? Lipoproteins? TNFa ? Anthropometric measurments and Esteatosis severity in Non ?€? alcoholic Fatty Liver Patients Whit Loss Weight Diet
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: non-alcoholic fatty liver. <br>Fatty ( change of ) liver , not elsewhere classified;Fatty ( change of ) liver , not elsewhere classified
Interventions: Intervention 1: intervention group :Extra Virgin Olive Oil, 20% of total daily energy requirement olive will be replaced with usual daily consumption of oil for every patients for 12 weeks. Intervention 2: control group :( not application )20% of total da
Outcome Measures: Serum ALT. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: IFCC,IU/D.;Sserum AST. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: IFCC,IU/D.;Steatosis severity. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: Sonography.TNF a. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: ELISA5,Pg/L.;Fasting TG. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: enzymetic method , mg / dl.;Insulin resistance. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: calculation.;Fasting insulin. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: Immunoassay radiometer,?U / ml.;FastingGlucose. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: Colorimetric method.mg / dl.;HDL - C. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: enzymetic method , mg / dl.;LDL - C. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: enzymetic method , mg / dl.;Total cholestrol. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: enzymetic method , mg / dl.;Percent body weight. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: Caliper, percent.;BMI. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: calculation,Kg / m2.;Waist circumference. Timepoint: BEFORE AND END OF INTERVENTION. Method of measurement: TAPE , Cm.
Sponsor/Collaborators: Vice-chancellor for Research, Tehran University of Medical Sciences
Gender: All
Age: 20 years60 years
Phases: Not applicable
Enrollment: 50
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
Start Date: 26/12/2011
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/2533